CapVest to acquire majority stake in STADA in multibillion-euro deal

Private equity group CapVest has agreed to acquire control of German pharmaceutical company STADA Arzneimittel in one of Europe’s largest healthcare transactions this year. The deal values the Bad Vilbel-based firm at about 10 billion euros ($11 billion), according to people familiar with the matter, nearly doubling its worth since 2017.

STADA, best known for its mix of generics, consumer health and specialty products, was taken private by Bain Capital and Cinven eight years ago for 5.3 billion euros. Both investors will retain minority stakes under the new agreement, reflecting confidence in the company’s growth prospects after helping transform it from a domestic generics player into a diversified global healthcare group.

Resilient growth and a broad portfolio